Table 3.
Association between CHG and prevalent CMM in the clinical dataset.
| CHG measure | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
| CHG (per 1 SD) | 1.85 (1.66—2.08) | <0.001 | 2.00 (1.78—2.24) | <0.001 | 1.96 (1.74—2.21) | <0.001 |
| CHG quartile | ||||||
| 1 | 1 (Ref) | 1 (Ref) | 1 (Ref) | |||
| 2 | 1.08 (0.91—1.27) | 0.390 | 1.13 (0.95—1.34) | 0.172 | 1.14 (0.96—1.36) | 0.136 |
| 3 | 1.09 (0.92—1.29) | 0.303 | 1.16 (0.98—1.38) | 0.083 | 1.18 (0.99—1.40) | 0.068 |
| 4 | 2.17 (1.85—2.55) | <0.001 | 2.37 (2.01—2.80) | <0.001 | 2.34 (1.97—2.78) | <0.001 |
Model 1 unadjusted; Model 2 adjusted for age, gender, educational level, smoking status, and drinking status; Model 3 adjusted for variables in Model 2 and BMI, SBP, WBC, CR, UA, hypertension, dyslipidemia and cancer.
OR, Odds Ratio; CI, Confidence Interval; Ref, reference.